1. Home

For Health Professionals

FDA Collaborates with Health Professional Societies, Trade Associations, and Academia

Topic Paragraphs
Learn how we collaborate Advisory Committees Training and Continuing Education MedWatch Patient Information
Call-To-Action Video

Call-To-Action Title
Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy

November 12, 2025 - FDA Commissioner and subject matter experts from the Center for Drug Evaluation and Research discussed the agency's recent announcement regarding the removal of the "black box warning" for hormone replacement therapy.

View Recording
Person using laptop with email graphics floating around

Subscribe to our e-newsletter

We know you're busy! The easiest way to keep up with us is to subscribe to our weekly e-newsletter.

You'll get the latest announcements, regulations, and upcoming events delivered to your email inbox every Monday.

Subscribe to the newsletter
Health professionals working together to report an adverse event.

How to Report Adverse Events to FDA MedWatch

Health professionals, consumers and patients can voluntarily report observed or suspected adverse events for human medical products to FDA. Voluntary reporting can help FDA identify unknown risk for approved medical products.

Learn More

MedWatch Safety Alerts

Paragraph Header

FDA VOICES: PERSPECTIVES FROM FDA EXPERTS

Image of spilled pills and with a light blue technological projection of various medical themed icons.

Ensuring Quality and Access: FDA’s Approach to Generic Drug Oversight

FDA continues to prioritize the speed and efficiency with which generic drugs are regulated, balancing the need for minimizing risk and ensuring access.
Four image collage capturing moments from the CDRH 50th Anniversary event and the 50th anniversary logo.

Fifty Years of the Medical Device Amendments: Building on a Strong Foundation to Advance Safe, Effective and High-Quality Medical Devices

For five decades, the 1976 Amendments have served as the foundation of a regulatory framework designed to protect patients.
Five panel photo collage. Image one, various types of color cometics. Image two, woman reading label on bottle of skin cream. Image three, bottles of different fragrences. Image four, color store shelves of various cosmetics. Image five, child wearing multi colored face paints.

How FDA is Implementing Landmark Cosmetics Legislation to Positively Impact Public Health

MoCRA expanded FDA’s authority over cosmetics and established new requirements for cosmetic companies and individuals who market cosmetics in the U.S.

FDA Center Resources for Health Professionals:

Drugs Medical Devices Biologics
Vet-Med Products Radiation-Emitting Products Cosmetics
Food Online Pharmacies Tobacco

Reach out today to talk about collaborating!

Public Engagement Staff
Office of External Affairs
Office of the Commissioner
Food and Drug Administration
10903 New Hampshire Ave WO32-5367
Silver Spring, MD 20993
United States

publicengagement@fda.hhs.gov

Hours Available

Public Engagement Staff

Paragraph Header (Column 2)
MedWatch Safety Alerts on X:

MedWatch

FDA MedWatch Safety Information
You know the moment it happens.
Follow @FDAMedWatch

Back to Top